Code of Maine Rules
10 - DEPARTMENT OF HEALTH AND HUMAN SERVICES
144 - DEPARTMENT OF HEALTH AND HUMAN SERVICES - GENERAL
Chapter 283 - NEWBORN BLOODSPOT SCREENING RULE
Appendix 144-283-B

Current through 2024-38, September 18, 2024

Time-critical Conditions

3-Hydroxy-3-Methyglutaric Aciduria (HMG) Argininosuccinic Aciduria (ASA) B-Ketothiolase Deficiency (BKT) Citrullinemia Type I (CIT) Classic Galactosemia (GALT) Congenital Adrenal Hyperplasia (CAH) Glutaric Acidemia Type I (GAI) Holocarboxylase Synthase Deficiency (MCD) Isovaleric Acidemia (IVA) Long-chain L-3 Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHAD) Maple Syrup Urine Disease (MSUD) Medium-chain Acyl-CoA Dehydrogenase Deficiency (MCAD) Methylmalonic Acidemia (MUT) Propionic Acidemia (PROP) Trifunctional Protein Deficiency (TFP) Very Long-chain Acyl-CoA Dehydrogenase Deficiency (VLCAD)

Disclaimer: These regulations may not be the most recent version. Maine may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.